Fund Overview of Pgim India Healthcare Fund Regular-growth
-
₹112.3 CrAUM
-
₹10.07NAV
-
2.37%Expense Ratio
-
EquityFund Category
Returns of Pgim India Healthcare Fund Regular-growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | -0.60% | NA | 6.12% |
| 6 Months | 9.52% | NA | 12.92% |
Asset Allocation
equities
97.50%debt instruments
1.48%other assets or cash equivalents
1.02%Pgim India Healthcare Fund Regular-growth is one Equity mutual fund offered by PGIM India Mutual Fund. Launched on 06 Dec 2024, the fund aims Long term capital growth. Investment in equity and equity related securities of pharmaceutical and healthcare companies. It manages assets worth ₹112.3 crore as on Thu Jul 31, 2025. , with a 52-week NAV range between ₹8.73 and ₹10.22. The expense ratio stands at 2.37%. Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager EducationAbout Pgim India Healthcare Fund Regular-growth
The portfolio allocation consists of 97.50% in equities, 1.48% in debt instruments, 1.02% in other assets or cash equivalents. Managed by Utsav Mehta, it has delivered a return of 0.00% in the last year, a total return since inception of -1.10%.
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | 0.21% | 0.48% | 9.03% | 28.99% | 21.62% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | 0.12% | 0.25% | 8.10% | 27.87% | 20.55% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | -0.03% | -1.35% | 5.10% | 23.18% | 17.50% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | -0.13% | -1.67% | 3.76% | 21.53% | 15.83% |
More funds from PGIM India Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Pgim India Healthcare Fund Direct-growth
|
₹112 | 0.10% | 1.19% | 4.81% | - | - |
|
Pgim India Healthcare Fund Regular-idcw
|
₹112 | -0.10% | 0.70% | 3.92% | - | - |
|
Pgim India Healthcare Fund Direct-idcw
|
₹112 | 0.10% | 1.19% | 4.81% | - | - |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹40.45 | 27.87% | 20.55% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹43.71 | 28.99% | 21.62% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹34.41 | 23.18% | 17.50% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹31.21 | 21.53% | 15.83% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹152.37 | 22.80% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.28 | 22.97% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.57% | ₹14.12 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.26% | ₹12.85 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.89% | ₹11.65 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.89% | ₹11.65 Cr |
| Divi's Laboratories Ltd | Healthcare | 9.82% | ₹10.50 Cr |
| Divi's Laboratories Ltd | Healthcare | 9.82% | ₹10.50 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.31% | ₹9.34 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.40% | ₹8.81 Cr |
| Max Healthcare Institute Ltd | Healthcare | 7.72% | ₹8.67 Cr |
| Max Healthcare Institute Ltd | Healthcare | 7.40% | ₹7.76 Cr |
| Max Healthcare Institute Ltd | Healthcare | 7.10% | ₹7.59 Cr |
| Max Healthcare Institute Ltd | Healthcare | 7.10% | ₹7.59 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 6.21% | ₹6.97 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 6.35% | ₹6.79 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 6.35% | ₹6.79 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 6.41% | ₹6.72 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 6.09% | ₹6.39 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 5.48% | ₹6.16 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 5.53% | ₹5.91 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 5.53% | ₹5.91 Cr |
| Mankind Pharma Ltd. | Healthcare | 5.13% | ₹5.76 Cr |
| Mankind Pharma Ltd. | Healthcare | 5.22% | ₹5.47 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.76% | ₹5.09 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.76% | ₹5.09 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.46% | ₹5.01 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 4.70% | ₹4.92 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 4.53% | ₹4.84 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 4.53% | ₹4.84 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.92% | ₹4.40 Cr |
| Rubicon Research Ltd. | 3.87% | ₹4.14 Cr | |
| Rubicon Research Ltd. | 3.87% | ₹4.14 Cr | |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.91% | ₹4.10 Cr |
| Abbott India Ltd | Healthcare | 3.64% | ₹4.09 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.69% | ₹3.95 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.69% | ₹3.95 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.49% | ₹3.92 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.52% | ₹3.76 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.52% | ₹3.76 Cr |
| Abbott India Ltd | Healthcare | 3.32% | ₹3.48 Cr |
| Global Health Ltd | Healthcare | 3.32% | ₹3.48 Cr |
| Abbott India Ltd | Healthcare | 3.25% | ₹3.47 Cr |
| Abbott India Ltd | Healthcare | 3.25% | ₹3.47 Cr |
| Global Health Ltd | Healthcare | 3.09% | ₹3.47 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.27% | ₹3.43 Cr |
| Pb Fintech Ltd | Financial | 2.85% | ₹3.20 Cr |
| Global Health Ltd | Healthcare | 2.93% | ₹3.13 Cr |
| Global Health Ltd | Healthcare | 2.93% | ₹3.13 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.90% | ₹3.11 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.90% | ₹3.11 Cr |
| Navin Fluorine International Ltd | Materials | 2.89% | ₹3.09 Cr |
| Navin Fluorine International Ltd | Materials | 2.89% | ₹3.09 Cr |
| Cipla Ltd | Healthcare | 2.73% | ₹3.06 Cr |
| Pb Fintech Ltd | Financial | 2.82% | ₹3.01 Cr |
| Pb Fintech Ltd | Financial | 2.82% | ₹3.01 Cr |
| Pb Fintech Ltd | Financial | 2.87% | ₹3.01 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.65% | ₹2.98 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 2.82% | ₹2.95 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.81% | ₹2.95 Cr |
| Navin Fluorine International Ltd | Materials | 2.58% | ₹2.89 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.68% | ₹2.81 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 2.58% | ₹2.76 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 2.58% | ₹2.76 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.57% | ₹2.75 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.57% | ₹2.75 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.56% | ₹2.74 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.56% | ₹2.74 Cr |
| Cipla Ltd | Healthcare | 2.59% | ₹2.71 Cr |
| Icici Lombard General Insurance Company Ltd | Financial | 2.40% | ₹2.70 Cr |
| Icici Lombard General Insurance Company Ltd | Financial | 2.53% | ₹2.65 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.35% | ₹2.64 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.36% | ₹2.47 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.30% | ₹2.45 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.30% | ₹2.45 Cr |
| Navin Fluorine International Ltd | Materials | 2.30% | ₹2.41 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.13% | ₹2.39 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.11% | ₹2.37 Cr |
| Sagility India Ltd. | Industrials | 2.07% | ₹2.33 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.20% | ₹2.30 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 2.04% | ₹2.29 Cr |
| Icici Lombard General Insurance Company Ltd | Financial | 2.12% | ₹2.26 Cr |
| Icici Lombard General Insurance Company Ltd | Financial | 2.12% | ₹2.26 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.00% | ₹2.25 Cr |
| Others Cblo | Unspecified | 1.93% | ₹2.17 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.05% | ₹2.15 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.95% | ₹2.04 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.82% | ₹1.95 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.82% | ₹1.95 Cr |
| Sagility India Ltd. | Industrials | 1.78% | ₹1.87 Cr |
| Syngene International Ltd | Healthcare | 1.66% | ₹1.86 Cr |
| Cipla Ltd | Healthcare | 1.71% | ₹1.83 Cr |
| Cipla Ltd | Healthcare | 1.71% | ₹1.83 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.62% | ₹1.73 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.62% | ₹1.73 Cr |
| Others Cblo | Unspecified | 1.62% | ₹1.69 Cr |
| Sanofi India Ltd | Healthcare | 1.50% | ₹1.69 Cr |
| Sagility India Ltd. | Industrials | 1.55% | ₹1.66 Cr |
| Sagility India Ltd. | Industrials | 1.55% | ₹1.66 Cr |
| Others Cblo | Unspecified | 1.48% | ₹1.58 Cr |
| Others Cblo | Unspecified | 1.48% | ₹1.58 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.37% | ₹1.53 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.27% | ₹1.33 Cr |
| Anthem Biosciences Ltd. | Healthcare | 1.07% | ₹1.21 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.02% | ₹1.14 Cr |
| Net Receivables | Unspecified | 1.02% | ₹1.08 Cr |
| Net Receivables | Unspecified | 1.02% | ₹1.08 Cr |
| Lenskart Solutions Ltd. | 0.94% | ₹1.00 Cr | |
| Lenskart Solutions Ltd. | 0.94% | ₹1.00 Cr | |
| Orchid Pharma Ltd | Healthcare | 0.78% | ₹0.87 Cr |
| Orchid Pharma Ltd | Healthcare | 0.80% | ₹0.86 Cr |
| Orchid Pharma Ltd | Healthcare | 0.80% | ₹0.86 Cr |
| Orchid Pharma Ltd | Healthcare | 0.79% | ₹0.83 Cr |
| Zydus Lifesciences Ltd | Healthcare | 0.73% | ₹0.76 Cr |
| Syngene International Ltd | Healthcare | 0.69% | ₹0.72 Cr |
| Dr. Agarwals Eye Hospital Ltd | Healthcare | 0.58% | ₹0.62 Cr |
| Dr. Agarwals Eye Hospital Ltd | Healthcare | 0.58% | ₹0.62 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 0.58% | ₹0.61 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 0.57% | ₹0.61 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 0.57% | ₹0.61 Cr |
| Dr. Agarwals Eye Hospital Ltd | Healthcare | 0.55% | ₹0.57 Cr |
| Dr. Agarwals Eye Hospital Ltd | Healthcare | 0.46% | ₹0.52 Cr |
| Zydus Lifesciences Ltd | Healthcare | 0.48% | ₹0.51 Cr |
| Zydus Lifesciences Ltd | Healthcare | 0.48% | ₹0.51 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 0.45% | ₹0.49 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 0.45% | ₹0.49 Cr |
| Blue Jet Healthcare Ltd. | Healthcare | 0.45% | ₹0.47 Cr |
| Net Receivables | Unspecified | 0.28% | ₹0.33 Cr |
| Net Receivables | Unspecified | 0.08% | ₹0.11 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹43.71 | 28.99% | 21.62% | 44.69 |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹40.45 | 27.87% | 20.55% | 41.47 |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹34.41 | 23.18% | 17.50% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹31.21 | 21.53% | 15.83% | - |
Pgim India Healthcare Fund Regular-growth
What is the current AUM of Pgim India Healthcare Fund Regular-growth?
As of Thu Jul 31, 2025, Pgim India Healthcare Fund Regular-growth manages assets worth ₹112.3 crore
How has Pgim India Healthcare Fund Regular-growth performed recently?
- 3 Months: -0.60%
- 6 Months: 9.52%
What is the portfolio composition of Pgim India Healthcare Fund Regular-growth?
Equity: 97.50%, Debt: 1.48%, Others: 1.02%.
Who manages Pgim India Healthcare Fund Regular-growth?
Pgim India Healthcare Fund Regular-growth is managed by Utsav Mehta from PGIM India Mutual Fund.
What is the market-cap allocation of Pgim India Healthcare Fund Regular-growth?
Large Cap: 44.40%, Mid Cap: 17.05%, Small Cap: 38.56%.
Which are the top companies Pgim India Healthcare Fund Regular-growth has invested in?
- Sun Pharmaceutical Industries Ltd – 12.57% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.26% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.89% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.89% of the fund's portfolio
- Divi's Laboratories Ltd – 9.82% of the fund's portfolio
Which are the major sectors Pgim India Healthcare Fund Regular-growth focuses on?
- Healthcare – 343.33% of the fund's portfolio
- Financial – 20.53% of the fund's portfolio
- Materials – 10.66% of the fund's portfolio
- – 9.62% of the fund's portfolio
- Unspecified – 8.91% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.


